In this study, we aimed to develop a novel method based on real-time PCR and high-resolution melting curve analysis (HRM) to simultaneously detect IDH1/2 and FLT3-TKD2 alterations in AML patients, using Sanger sequencing as confirmation. This evidence concerns the gene FLT3 and acute myeloid leukemia.